Thermo Fisher Scientific Launches New Products and Makes Acquisitions to Spur Growth

Thermo Fisher’s market leadership, diversified revenue streams, and demonstrated ability to execute strategic initiatives in challenging market conditions makes it stand out. Its comprehensive portfolio spanning analytical instruments, laboratory products, specialty diagnostics, and biopharma services creates a diversified revenue base that reduces cyclical risks while providing multiple growth opportunities.

Long term, Thermo Fisher’s strategic positioning in the life sciences industry provides exposure to ongoing growth trends including aging demographics, personalized medicine, and biotechnology innovation.

THERMO FISHER SCIENTIFIC INC. (New York symbol TMO; www.thermofisher.com) lets you tap a leading manufacturer of scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents.

In the quarter ended March 29, 2025, Thermo Fisher’s revenue rose slightly, to $10.36 billion from $10.35 billion a year earlier. Excluding one-time items, per-share earnings climbed 0.8%, to $5.15 from $5.11.

[ofie_ad]

The company continues to launch new products. This includes its recent introduction of its Thermo Scientific TruNarc Delta and Tau Handheld Narcotics Analyzers to help communities combat known and emerging narcotics and illicit substances.

The user-friendly devices feature touchless technology and an expanded chemical library, aimed at empowering frontline law enforcement officials to detect more than 1,200 substances in the field, including stimulants, depressants, hallucinogens and analgesics—even at low concentrations or in mixtures—in seconds.

The latest development builds on the company’s first-generation TruNarc analyzer, launched in 2012 and adopted by law enforcement agencies in all 50 states and in more than 50 countries to date.

Notably, law enforcement officials face an increased risk of unintentional exposure and challenges with accurately identifying dangerous substances in the field. The company’s TruNarc analyzers aim to enable them to test substances they seize from a safe distance, helping stop the flow of drugs across borders.

Thermo Fisher’s new TruNarc analyzers come with automated record keeping that generates documentation with complete scan data, including time-and-date stamps, to expedite prosecution and secure legal integrity. As drug substances continue to evolve and become harder to identify, the on-device chemical library of the TruNarc analyzer is updated regularly to keep pace with new and emerging illicit drug threats.

Major acquisition expands Thermo Fisher Scientific’s product portfolio

Thermo Fisher is now buying Solventum’s purification and filtration business for $4.1 billion in cash.

Solventum (symbol SOLV on New York) is a healthcare company that was spun off by 3M (symbol MMM on New York) on April 1, 2024. Solventum makes products to treat and prevent infection in wounds; it also manufactures dental filling materials, and filtration and purification products.

Solventum’s purification and filtration business reported about $1 billion in revenue in 2023. Its technologies are used in the production of biologics and medical devices and for industrial applications. The business employs about 2,500 people globally and will become part of Thermo Fisher’s life sciences solutions segment.

The business should be highly complementary to Thermo Fisher’s bioproduction unit. Today, Thermo Fisher has a leading portfolio of offerings in cell culture media and single-use technologies. Solventum’s innovative filtration portfolio broadens Thermo Fisher’s capabilities in the development and manufacturing of biologics, spanning upstream and downstream workflows.

The company’s success with health technology should continue producing substantial gains.

Overall, Thermo Fisher has relied on acquisitions for growth; it also has a high p/e and low yield. That combination leaves the company’s shares vulnerable to a sharp setback on bad corporate news or overall stock market weakness.

Still, the company’s success with health technology could produce substantial gains.

Recommendation in Power Growth Investor: Thermo Fisher Scientific Inc. is a buy.

Copy
Link copied
Email
Print

acquisition portfolio

Scott Clayton

Scott is an associate editor at TSI Network. He is the lead reporter and analyst for Dividend Advisor, Power Growth Investor and Canadian Wealth Advisor and a member of the Investment Planning Committee. Scott began his investment and financial career working with Pat McKeough at The Investment Reporter in the 1980s. Subsequently, he worked at the Financial Post Corporation Service for 10 years. He joined TSI Network in 1998. He is a Bachelor of Economics graduate of York University, and he also has an M.B.A. from the Schulich School of Business.

Find 5 Safe Stocks to
Buy & Hold for Long-Term
Growth and Steady Income

No Credit Card Required

SEND ME THIS FREE REPORT

Testimonials

The cornerstones of Pat’s strategy–value, diversification and timelines–make his newsletter, The Successful Investor, highly profitable while minimizing risk. His advice is no-nonsense, down-to-earth and based on solid research. You’ll know what to invest in and what to avoid.

Chuck Chakrapani, PhD
Investors Association of Canada
The older I get the better dividends look. For retirees and would-be retirees who want to sleep at night, I can’t think of a better source of information on reliable growing dividend income than Pat McKeough’s newsletter, Dividend Advisor.

Jonathan Chevreau
Financial Post Columnist
As a manager of more than $500 million in mutual funds, I have access to the best brokerage research available in this country. But I still take time to read Pat McKeough’s premium newsletters

John Sartz
I appreciate the 25 years of above market returns I received by following your advice. at least 95% of my investment decisions were based on TSI recommendations.

Chuck J.
Subscriber since 1996. Inner Circle Member Since 2006
The newsletters I receive in Inner Circle Pro are fantastic! I have been following Pat’s advice for years and everything he has said has been amazing. His commentaries are brilliant, insightful, educational, rational and balanced. My returns are almost double the TSE and I have referred many of my friends who have switched over to your services.

Walter H.
Inner Circle Pro subscriber

Free Reports

5 Best Stocks to Buy This Month

The Successful Investor Approach to AI Investing

7 Winning Strategies for Dividend Investors

The Best Blue Chips for Canadian Investors

The ETF Investor’s Handbook

The Canadian Guide on How to Invest in Stocks Successfully

Power and Profits of Energy Stocks

Juniors to Giants: The Complete Guide to Mining Stocks

How to Find the Best Growth Stocks

7 Pro Secrets to Value Investing

Browse Topics

Blue Chip Stocks

Blue chip stocks are big, well-established, dividend-paying corporations with strong business prospects. These are companies that also have sound management that should be able to make the right moves to keep competing successfully in a changing marketplace.

Dividend Stocks

Dividend stocks make cash payouts that serve as a way for companies to share the wealth they’ve accumulated. These payouts are drawn from earnings and cash flow and paid to the shareholders of the company. Typically, these dividends are paid quarterly, although they may be paid annually or even monthly as well.

Value Stocks

What are value stocks?

One of the sweetest and most profitable pleasures of successful investing is to buy high-quality “value stocks” (or stocks that are reasonably priced, if not cheap, in relation to its sales, earnings or assets), then hold on to them as mainstream investors recognize the value and push up the share price.

Growth Stocks

Growth stocks are companies that are likely to have sales and earnings growth well above market average. Frequently they pay few, if any, dividends. Instead they typically reinvest any extra cash flow to promote further growth. Chosen wisely—according to Pat McKeough’s advice—high-quality growth-oriented stocks can be worthwhile additions to most well-diversified portfolios.

ETFs

What are ETFs?

ETF is an acronym for exchange traded fund.. These exchange traded funds are used to track indexes as closely as possible, since investors cannot actually buy an index outright.

How To Invest

Pat McKeough has been making investing for beginners simple—and profitable—by helping investors make big gains for more than 25 years. His advice to beginning investors is the same as it is for all investors: buy high-quality, mostly dividend paying stocks (or ETFs that hold these stocks) and evenly spread your investments over the five main economic sectors (Resources, Manufacturing, Finance, Utilities and Consumer). Pat also believes investors should avoid stocks in the broker/media limelight and focus on those with hidden or little-noticed assets.

Wealth Management

Wealth management is the practice of putting your savings to work so that it continues to grow over your lifetime and will also benefit your heirs. Wealth management encompasses many different areas of investing like long term investment planning and retirement planning.

AI Investing

Artificial intelligence (AI) is essentially the merging of today’s big computing with big data. This has resulted in breakthroughs in everything from creating machines to recognize faces with more accuracy than a human, to the development of chatbots able to collect, organize and simplify all the Internet has to say on any topic.

Spinoffs

One of the ways a company can try to unlock its own hidden value is by creating a separate company out of a corporate subsidiary. The parent company can either sell stock in the new company to the public, or spin it off—hand the stock out to its own investors.

Penny Stocks

A penny stock in general trades for under five dollars a share, and as the name implies, sometimes for pennies. Most of the time they’re young companies, or start-ups in speculative markets like mining or technology.

Mining Stocks

Mining stocks are investments in companies that produce or explore for minerals. Some of these minerals include uranium, coal, molybdenum (which is used in steelmaking), copper, silver and gold. They are affected by fluctuating commodity prices in addition to their own business and operating risks.

Energy Stocks

What are energy stocks?

Businesses that work in the extraction, refining and delivery of energy sources such as natural gas, oil, uranium and coal, are considered energy stocks.